OBI Pharma (ROCO:4174) EV-to-Revenue : 247.74 (As of Jun. 23, 2024)

View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, OBI Pharma's enterprise value is NT$12,114.01 Mil. OBI Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$48.90 Mil. Therefore, OBI Pharma's EV-to-Revenue for today is 247.74.

The historical rank and industry rank for OBI Pharma's EV-to-Revenue or its related term are showing as below:

ROCO:4174' s EV-to-Revenue Range Over the Past 10 Years
Min: 140.02 Med: 1386.29 Max: 89712.11
Current: 247.74

During the past 13 years, the highest EV-to-Revenue of OBI Pharma was 89712.11. The lowest was 140.02. And the median was 1386.29.

ROCO:4174's EV-to-Revenue is ranked worse than
90.14% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs ROCO:4174: 247.74

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), OBI Pharma's stock price is NT$61.00. OBI Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$0.21. Therefore, OBI Pharma's PS Ratio for today is 286.38.

OBI Pharma EV-to-Revenue Historical Data

The historical data trend for OBI Pharma's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OBI Pharma EV-to-Revenue Chart

OBI Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

3,688.38

175.88

1,143.94

2,714.28

355.61

OBI Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															3,019.85	1,522.21	724.36	355.61	276.94

Competitive Comparison of OBI Pharma's EV-to-Revenue

For the Biotechnology subindustry, OBI Pharma's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OBI Pharma's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where OBI Pharma's EV-to-Revenue falls into.

OBI Pharma EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

OBI Pharma's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	12114.006	/	48.898
	=	247.74

OBI Pharma's current Enterprise Value is NT$12,114.01 Mil.
OBI Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$48.90 Mil.

OBI Pharma (ROCO:4174) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

OBI Pharma's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	61.00	/	0.213
	=	286.38

OBI Pharma's share price for today is NT$61.00.
OBI Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.21.

OBI Pharma EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of OBI Pharma's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

OBI Pharma (ROCO:4174) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, Room. 1907, 19th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.obipharma.com

OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The Group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.

OBI Pharma (ROCO:4174) Headlines

No Headlines